Evidence map›Paper›PMID 41912490›Full record

ArticleCell death & disease2026

Ndfip2 in TrkA-expressing sensory neurons regulates noxious mechanosensation through control of TrkA signaling and protein levels.

Daniel Cañada-García, Ana Hernández-García, Cristina Vicente-García, Jorge Valero, Maurilyn Ayon-Olivas, Sharad Kumar, Michael Sendtner, Juan Carlos Arévalo

Abstract read
In one paragraph

Article in Cell death & disease, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Daniel Cañada-GarcíaDepartment of Cell Biology and Pathology, Instituto de Neurociencias de Castilla y León (INCyL), Universidad de Salamanca, Salamanca, Spain. danielcg@usal.es.ORCID http://orcid.org/0000-0002-2426-0734
Ana Hernández-GarcíaDepartment of Cell Biology and Pathology, Instituto de Neurociencias de Castilla y León (INCyL), Universidad de Salamanca, Salamanca, Spain.
Cristina Vicente-GarcíaDepartment of Cell Biology and Pathology, Instituto de Neurociencias de Castilla y León (INCyL), Universidad de Salamanca, Salamanca, Spain.
Jorge ValeroDepartment of Cell Biology and Pathology, Instituto de Neurociencias de Castilla y León (INCyL), Universidad de Salamanca, Salamanca, Spain.
Maurilyn Ayon-OlivasInstitute of Clinical Neurobiology, University Hospital Wuerzburg, Wuerzburg, Germany.
Sharad KumarCentre for Cancer Biology, College of Heath, Adelaide University, Adelaide, SA, Australia.ORCID http://orcid.org/0000-0001-7126-9814
Michael SendtnerInstitute of Clinical Neurobiology, University Hospital Wuerzburg, Wuerzburg, Germany.ORCID http://orcid.org/0000-0002-4737-2974
Juan Carlos ArévaloDepartment of Cell Biology and Pathology, Instituto de Neurociencias de Castilla y León (INCyL), Universidad de Salamanca, Salamanca, Spain. arevalojc@usal.es.ORCID http://orcid.org/0000-0003-1994-3095

Funding

Department of Health | National Health and Medical Research Council (NHMRC) 2007739Deutsche Forschungsgemeinschaft (German Research Foundation) KFO 5001 ResolvePAIN SE697/9-1EC | EC Seventh Framework Programm | FP7 Health (FP7-HEALTH - Specific Programme "Cooperation": Health) 603191Ministry of Economy and Competitiveness | Agencia Estatal de Investigación (Spanish Agencia Estatal de Investigación) PID2020-113130RB-100Ministry of Economy and Competitiveness | Agencia Estatal de Investigación (Spanish Agencia Estatal de Investigación) PID2023-1473290-I00
6 · The paper itself

Abstract

Nociception, the neural process underlying pain detection, is modulated by the NGF/TrkA signaling axis. Although anti-NGF antibodies can alleviate chronic pain, their clinical application is limited by adverse effects, underscoring the need to identify downstream regulators of this pathway. One such mechanism involves TrkA ubiquitination mediated by Nedd4 E3 ubiquitin ligases, whose activity is modulated by Nedd4 family interacting protein 2 (Ndfip2). Notably, Ndfip2 expression is regulated by TrkA signaling under pain conditions. Here, we characterize the physiological and molecular roles of Ndfip2 in sensory neurons. We demonstrate that Ndfip2 localizes to the endoplasmic reticulum and Golgi apparatus and interacts with TrkA in sensory neurons. Conditional deletion of Ndfip2 in TrkA-expressing cells selectively alters mechanical nociception. Mechanistically, loss of Ndfip2 decreases total TrkA protein levels, downstream activation, and cell-surface exposition, particularly in male-derived dorsal root ganglia neurons. Conversely, Ndfip2 expression reduces mature glycosylated TrkA and promotes the accumulation of non-glycosylated forms, consistent with impaired receptor maturation. Together, these findings identify Ndfip2 as a post-translational regulator of TrkA in TrkA-lineage sensory neurons and establish its in vivo role in mechanical nociception.

Indexed as

Mechanotransduction, CellularMembrane ProteinsReceptor, trkASensory Receptor CellsAnimalsEndoplasmic ReticulumGanglia, SpinalGolgi ApparatusHumansMaleMiceNociceptionSignal TransductionMembrane ProteinsReceptor, trkA

Identifiers

PMID41912490
PMCPMC13158297

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.